MacroGenics Company Insiders

MacroGenics Management Team Effectiveness

The company has return on total asset (ROA) of (0.2215) % which means that it has lost $0.2215 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6217) %, meaning that it created substantial loss on money invested by shareholders. MacroGenics' management efficiency ratios could be used to measure how well MacroGenics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.04 in 2025. Return On Capital Employed is likely to rise to -0.76 in 2025. At this time, MacroGenics' Net Tangible Assets are fairly stable compared to the past year. Debt To Assets is likely to rise to 0.11 in 2025, whereas Total Assets are likely to drop slightly above 287.5 M in 2025. Common Stock Shares Outstanding is likely to drop to about 42.1 M in 2025. Net Loss is likely to drop to about (113.2 M) in 2025

MacroGenics Workforce Comparison

The company has Profit Margin (PM) of (0.69) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.49 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.49.

MacroGenics Insider Trading History

MacroGenics Notable Stakeholders

The success or failure of an entity such as MacroGenics often depends on how effective the management is. MacroGenics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MacroGenics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MacroGenics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in MacroGenics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MacroGenics. Check MacroGenics' Beneish M Score to see the likelihood of MacroGenics' management manipulating its earnings.

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.